Peripheral blood stem cells (PBSCs) are increasingly used as the source of hematopoietic stem cells, but there are large variations in harvest outcome between individuals mobilized by granulocyte colony-stimulating factor (G-CSF). We examined the effects of donor characteristics and procedure factors on the day 1 CD34+ cell yield in 373 unrelated healthy donors. G-CSF was administered subcutaneously at a planned dose of 8.3 to 11μg/kg daily for 5 days, followed by harvest started on day 5 of G-CSF treatment. Of the 373 donors, 159 (42.6%) had the radial artery as the inlet access for harvest. Poor day 1 cell yield was defined as < 10 × 106 CD34+ cells/L of processed blood for the first apheresis; 62 donors (16.6%) did not attain this thresh...
In this study, we assessed the functional and kinetic characteristics of highly purified hematopoiet...
We report graft product stem cell yields and donor safety results of a randomized multicenter study ...
Peripheral blood stem cells (PBSC) have been used for transplantation since the early 1990s. CD34+ h...
Peripheral blood stem cells (PBSCs) are increasingly used as the source of hematopoietic stem cells,...
This study was aimed to explore the factors impacting on effect of the recombinant human granulocyte...
Background: A second allogeneic hematopoietic stem-cell transplantation and donor lymphocyte infusio...
Background The effects of donor characteristics on CD34(+) cell dose remain controversial. Recently,...
We evaluated stem cell mobilization in 195 consecutive sibling donors who underwent a uniform mobili...
Peripheral blood stem cells (PBSCs) collected following stimulation with cytokines are commonly used...
Background: In the past two decades peripheral blood stem cells (PBSCs) have increasingly replaced m...
We studied peripheral blood and apheresis samples from 39 consecutive normal donors who were parents...
PubMed ID: 26043813Most frequently used graft of hematopoietic stem cells (HSCs) for allogeneic tran...
AbstractLittle information exists on the effect of race and ethnicity on collection of peripheral bl...
Objectives Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment...
BackgroundAllogeneic hematopoietic stem cell transplantation is associated with a high risk of immun...
In this study, we assessed the functional and kinetic characteristics of highly purified hematopoiet...
We report graft product stem cell yields and donor safety results of a randomized multicenter study ...
Peripheral blood stem cells (PBSC) have been used for transplantation since the early 1990s. CD34+ h...
Peripheral blood stem cells (PBSCs) are increasingly used as the source of hematopoietic stem cells,...
This study was aimed to explore the factors impacting on effect of the recombinant human granulocyte...
Background: A second allogeneic hematopoietic stem-cell transplantation and donor lymphocyte infusio...
Background The effects of donor characteristics on CD34(+) cell dose remain controversial. Recently,...
We evaluated stem cell mobilization in 195 consecutive sibling donors who underwent a uniform mobili...
Peripheral blood stem cells (PBSCs) collected following stimulation with cytokines are commonly used...
Background: In the past two decades peripheral blood stem cells (PBSCs) have increasingly replaced m...
We studied peripheral blood and apheresis samples from 39 consecutive normal donors who were parents...
PubMed ID: 26043813Most frequently used graft of hematopoietic stem cells (HSCs) for allogeneic tran...
AbstractLittle information exists on the effect of race and ethnicity on collection of peripheral bl...
Objectives Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment...
BackgroundAllogeneic hematopoietic stem cell transplantation is associated with a high risk of immun...
In this study, we assessed the functional and kinetic characteristics of highly purified hematopoiet...
We report graft product stem cell yields and donor safety results of a randomized multicenter study ...
Peripheral blood stem cells (PBSC) have been used for transplantation since the early 1990s. CD34+ h...